Back to ALL Research Publications
Research Category: Burns, Cost-Savings/ Reimbursement
The utility of MolecuLight bacterial sensing in the management of burns and traumatic wounds
References
Steven Jeffery
Consultant Burns and Plastic Surgeon, The Queen Elizabeth Hospital, Birmingham, UK
Professor of Wound Study, Birmingham City University, Honorary Visiting Professor, University of Cardiff
Find out how to make a difference in wound care
MolecuLight is SOC ll®
Type l Accredited:
MolecuLight awarded
Premier’s Technology
Breakthrough Designation
MolecuLight i:X
is designated as a:
MolecuLight included
in ISWCAP Consensus
Guidelines:
MolecuLight is a proud
corporate member of:
Global
USA
©2024
The MolecuLight® i:X and MolecuLightDX™ Imaging Devices are approved by Health Canada for sale in Canada and has CE marking for sale in the European Union.
The MolecuLight™ i:X and DX Imaging Devices have received FDA clearance.